Review
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
Fecha
2019Registro en:
113, , -
07533322
Autor
Manzine P.R.
Ettcheto M.
Cano A.
Busquets O.
Marcello E.
Pelucchi S.
Di Luca M.
Endres K.
Olloquequi J.
Camins A.
Cominetti M.R.
Institución
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein [Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide]
Folch J.; Ettcheto M.; Petrov D.; Abad S.; Pedrós I.; Marin M.; Olloquequi J.; Camins A. (Spanish Society of Neurology, 2018) -
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease
Zainaghi, Isis A.; Talib, Leda L.; Diniz, Breno S.; Gattaz, Wagner F.; Forlenza, Orestes V. (SPRINGER WIENWIEN, 2012)Studies have shown that platelet APP ratio (representing the percentage of 120-130 kDa to 110 kDa isoforms of the amyloid precursor protein) is reduced in patients with mild cognitive impairment (MCI) and Alzheimer's disease ...